Organization | Shanghai University of Traditional Chinese Medicine

Shanghai University of Traditional Chinese Medicine Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Shanghai China (1956)

Organization Overview

First Clinical Trial

2007

NCT00543426

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Bing Shu | Center for Drug Clincal Reserch Shanghai University of TCM | Cui xuejun | Department of dermatology, Shanghai Yueyang Integrated Medicine Hospital, Shanghai | Department of dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai | Ethics Committee of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine | lihegen | Longhua hospital affiliated to Shanghai Uni of TCM | Longhua Hospital Shanghai University of Traditional Chinese Medicine | Shanghai Innovative Research Center of Traditional Chinese Medicine | Shanghai Institute of Acupuncture, Moxibustion and Meridian | Shanghai Institute of Acupuncture-Moxibustion and Meridian, Shanghai University of Traditional Chinese Medicine | Shanghai Municipal Hospital of Traditional Chinese Medicine | Shanghai Putuo District Center Hospital | Shanghai Seventh People's Hospital | Shanghai Univercity of TCM | Shanghai Universitu of TCM | Shanghai University of Chinese Medicine | Shanghai University of TCM | Shanghai University of T.C.M. | Shanghai University of Traditional Chinese Medicine | Shanghai University of Traditional Chinese Medicine affliated Yueyang Hospital | Shanghai University of Traditional Chinese Medincine Afflicated Longhua Hospital | Shanghai UTCM | Shanghai Yueyang Integrated Medicine Hospital | Shanghai Yueyang Integrated Medicine Hospital, Shanghai | ShuGuang Hospital | Shuguang Hospital affiliated with Shanghai University of TCM | Shuguang Hospital Affiliated with Shanghai University of TCM | Shuguang hospital of Shanghai university of traditional Chinese medicine | the chief of the neurology department, Shuguang Hospital of Shanghai University of Chinese Traditional Medicine | wanglin | xuling | Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine | Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM | Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine | Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine

Active Ingredients

Drugs in Phase 4 Trials (18)

carvedilol (coreg) (3 trials)

deng zhan sheng mai (1 trial)

entecavir (baraclude) (4 trials)

fuzhenghuayu (6 trials)

fuzheng huayu (2 trials)

heweizhixie (1 trial)

indomethacin (indocin) (1 trial)

levofloxacin (levaquin) (1 trial)

nadroparin (1 trial)

naoxintong (1 trial)

qishen (3 trials)

shengdi dahuang (1 trial)

tenofovir alafenamide (genvoya) (1 trial)

warfarin (coumadin) (1 trial)

yangzhengxiaoji (1 trial)

zushima (1 trial)

Drugs in Phase 3 Trials (55)

acetylsalicylic acid (aspirin) (2 trials)

astragalus membranaceus (2 trials)

baidi quizhi (1 trial)

bawei shenqi (1 trial)

bufei yishen (1 trial)

capecitabine (xeloda) (1 trial)

carboplatin (paraplatin) (1 trial)

cisplatin (platinol) (3 trials)

docetaxel (taxotere) (4 trials)

erlotinib (tarceva) (1 trial)

fluorouracil (efudex) (1 trial)

fructus corni (1 trial)

fructus schizandrae (1 trial)

gefitinib (iressa) (2 trials)

gemcitabine (gemzar) (2 trials)

gimeracil (1 trial)

ginkgo biloba (2 trials)

ginkgo diterpene lactone meglumine (1 trial)

huangqi (2 trials)

huang qi gui zhi wu (1 trial)

icotinib (Conmana) (1 trial)

jinfukang (2 trials)

jinfukang koufuye (1 trial)

juanbi (1 trial)

ju yin (1 trial)

meloxicam (mobic) (1 trial)

naltrexone (revia) (1 trial)

nedaplatin (1 trial)

niubangzi (1 trial)

oteracil (1 trial)

oxaliplatin (eloxatin) (1 trial)

paclitaxel (taxol) (1 trial)

pemetrexed (alimta) (4 trials)

qing'e (2 trials)

qi-zheng-xiao-tong (1 trial)

radix polygoni multiflori (1 trial)

radix rehmanniae (1 trial)

radix smilax china (1 trial)

radix stephaniae tetrandrae (1 trial)

rhizoma atractylodis macrocephalae (2 trials)

rhizoma dioscoreae (1 trial)

tang-min ling (1 trial)

tcm-700c (1 trial)

tegafur (1 trial)

thrombopoietin (1 trial)

tiotropium (spiriva) (1 trial)

tong-luo-qu-tong (1 trial)

vinorelbine (navelbine) (1 trial)

xingzaoruanjian (1 trial)

yangyinfang (2 trials)

yiqifang (2 trials)

yiqiyangyinfang (2 trials)

yiqi-yangyin-jiedu (1 trial)

zishenqinggan (1 trial)

Drugs in Phase 2 Trials (33)

acetylcysteine (mucomyst) (1 trial)

benfluorex (1 trial)

boric acid (1 trial)

budesonide (rhinocort) (1 trial)

bu shen na qi (1 trial)

chanqin (1 trial)

chuan xiong ping chuan (1 trial)

dan ma jia (1 trial)

etoposide (vepesid) (1 trial)

etoricoxib (Gencox) (1 trial)

formoterol (foradil) (1 trial)

furoic acid (1 trial)

huzhang (1 trial)

jia wei yang he (1 trial)

jueyin (3 trials)

ke chuan liu wei (2 trials)

liuwei dihuang (1 trial)

loperamide (imodium) (1 trial)

qinbudan (1 trial)

sailuotong (1 trial)

sitagliptin (januvia) (1 trial)

taodan (1 trial)

tenecteplase (tnkase) (1 trial)

weiyang yuping fang (1 trial)

xie wu (1 trial)

yang he ping chuan (1 trial)

yougui (1 trial)

yuxintine (1 trial)

zhi chuan (1 trial)

zhigancao (1 trial)

zinc dichloride (1 trial)

zl-3101 (1 trial)

zuogui (1 trial)

Drugs in Phase 1 Trials (9)

amp-1915 (1 trial)

avibactam (Avycaz) (1 trial)

bushen-jianpi (1 trial)

ceftazidime (fortaz) (1 trial)

cinobufotalin (1 trial)

mianhuahua flavonoids (1 trial)

shenqidihuang (1 trial)

sodium chloride (2 trials)

weifuchun (1 trial)

Drugs in Other Trials (39)

amantadine (symmetrel) (1 trial)

artemisia (1 trial)

azimtamide (1 trial)

betahistine mesilate (1 trial)

dexmedetomidine (precedex) (1 trial)

donepezil (aricept) (2 trials)

gardenia jasminoides ellis (1 trial)

huangkui (3 trials)

ixekizumab (taltz) (1 trial)

jianpixiaozhong (1 trial)

losartan (cozaar) (1 trial)

melatonin (1 trial)

paeoniae radix (1 trial)

pinellia (1 trial)

prednisone (meticorten) (2 trials)

propofol (diprivan) (1 trial)

qingre liangkou ningxin fang (1 trial)

qingremoshen (1 trial)

radix curcumae (1 trial)

radix scutellariae (1 trial)

rhizoma atractylodis (1 trial)

rhizoma coptidis (1 trial)

rhizoma zingiberis (1 trial)

roasted bighead atractylodes rhizome (1 trial)

rubia cordifolia (1 trial)

salvia (1 trial)

sevoflurane (ultane) (1 trial)

shentong (1 trial)

shugan (1 trial)

sibelium (1 trial)

sieyesbeckiaorientalis (1 trial)

simethicone (IMODIUM) (1 trial)

spreading hedyotis herb (1 trial)

tianqi pingchan (1 trial)

tolterodine (detrol) (1 trial)

weiqi (1 trial)

yanqing zhitong (1 trial)

yin and yang (1 trial)

zibuganshen (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Adenocarcinoma (Phase 3)

Adenocarcinoma of Lung (Phase 3)

Arthritis (Phase 3)

Arthritis, Gouty (Phase 2)

Arthritis, Rheumatoid (Phase 3)

Asthma (Phase 2)

Atrophy (Phase 1)

Blind Loop Syndrome (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma, Hepatocellular (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Cerebral Infarction (Phase 4)

Chronic Kidney Disease-Mineral and Bone Disorder (Phase 2)

Communicable Diseases (Phase 4)

Cough (Phase 2)

Dementia (Phase 2)

Dementia, Vascular (Phase 2)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Major (Phase 2)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Diabetic Nephropathies (Phase 1)

Diarrhea (Phase 4)

Disease (Phase 4)

Eczema (Phase 2)

Esophageal and Gastric Varices (Phase 4)

Fibrosis (Phase 4)

Gastritis (Phase 1)

Gastritis, Atrophic (Phase 1)

Heart Failure (Phase 2)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hyperplasia (Phase 1)

Hypertension (Phase 4)

Hypertension, Portal (Phase 4)

Infections (Phase 4)

Intracranial Hemorrhages (Phase 4)

Ischemia (Phase 4)

Liver Cirrhosis (Phase 4)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Lung Neoplasms (Phase 3)

Lupus Erythematosus, Systemic (Phase 3)

Metabolic Syndrome (Phase 1)

Musculoskeletal Diseases (Phase 3)

Neoplasms (Phase 1)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Parasomnias (Phase 4)

Pneumonia (Phase 4)

Psoriasis (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Pulmonary Fibrosis (Phase 2)

Radiculopathy (Phase 4)

Renal Insufficiency (Phase 2)

Renal Insufficiency, Chronic (Phase 2)

Sepsis (Phase 3)

Sleep Wake Disorders (Phase 4)

Spondylitis (Phase 3)

Spondylitis, Ankylosing (Phase 3)

Stomach Neoplasms (Phase 3)

Stroke (Phase 4)

Syndrome (Phase 1)

Thrombocytopenia (Phase 3)

Thrombosis (Phase 4)

Toxemia (Phase 3)

Tuberculosis (Phase 2)

Tuberculosis, Pulmonary (Phase 2)

Urinary Tract Infections (Phase 4)

Venous Thrombosis (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 98
# of Trial APIs: 154